inviCRO
Invicro, founded in 2008, is a specialized imaging services company that focuses on the application of imaging biomarkers in drug development and clinical research.
Profile
Provides advanced imaging services for drug development and clinical research.
Invicro, founded in 2008, is a specialized imaging services company that focuses on the application of imaging biomarkers in drug development and clinical research. The company has carved out a niche in preclinical and in vivo imaging, offering services that help pharmaceutical and biotechnology companies accelerate their research and development processes. Invicro’s expertise spans multiple therapeutic areas, including oncology, neuroscience, and radiopharmaceutical therapy.
The company operates globally, with multiple imaging facilities and strategic collaborations that enhance its capabilities and scalability. Invicro has supported over 3,000 studies, leveraging its advanced imaging technologies and analytical methods to provide high-quality data for its clients. The company’s financial trajectory has been steady, with a focus on expanding its service offerings and geographic reach. Recent developments indicate a continued emphasis on innovation in imaging biomarkers and radiopharmaceutical therapy, positioning Invicro as a key player in the evolving landscape of drug development.
Who buys this
- Pharmaceutical companies
- Biotechnology firms
- Clinical research organizations
- Academic research institutions
Strengths and what to watch
Strengths
- Extensive experience with over 3,000 studies supported
- Global research infrastructure with multiple imaging facilities
- Advanced analytical methods for precise data interpretation
Watch for
- Dependence on a few key clients for revenue
- Competition from other imaging service providers
- Regulatory challenges in new therapeutic areas
Key Information
- Founded
- 2008
Frequently Asked Questions
What does Invicro specialize in?
Invicro provides advanced imaging services for drug development and clinical research, specializing in imaging biomarkers. Founded in 2008, it supports pharmaceutical and biotech companies with preclinical and in vivo imaging across oncology, neuroscience, and radiopharmaceutical therapy. The company has supported over 3,000 studies globally.
How does Invicro support drug development?
Invicro accelerates drug development through specialized imaging services that provide precise data on drug effects. Their imaging biomarkers help evaluate treatment efficacy in preclinical and clinical stages. With global facilities and advanced analytics, they deliver actionable insights for pharmaceutical and biotech research programs.
What therapeutic areas does Invicro focus on?
Invicro concentrates on oncology, neuroscience, and radiopharmaceutical therapy imaging. Their expertise in these areas helps researchers track disease progression and treatment responses. The company's imaging biomarkers provide critical data for developing targeted therapies across these specialized medical fields.
Where are Invicro's imaging facilities located?
Invicro operates multiple imaging facilities globally, though specific locations aren't detailed. Their international infrastructure supports pharmaceutical and biotech clients worldwide, enabling large-scale studies. This geographic reach facilitates collaborative research across different regions and regulatory environments.
What makes Invicro different from other imaging providers?
Invicro stands out through its 3,000+ completed studies and therapeutic specialization. Their focus on imaging biomarkers in oncology and neuroscience, combined with global capabilities, offers unique value. Advanced analytical methods ensure high-quality data interpretation for complex drug development challenges.
Who typically uses Invicro's services?
Pharmaceutical companies, biotech firms, clinical research organizations, and academic institutions partner with Invicro. These clients leverage Invicro's imaging expertise to accelerate research, particularly in oncology and neuroscience. The company's services help streamline drug development from preclinical stages through clinical trials.
Sources
- www.linkedin.com — Invicro's specialization in imaging biomarkers in drug development
- www.invicro.com — Invicro's focus on imaging services for drug development
- invicro.com — Invicro's expertise in oncology imaging
- invicro.com — Invicro's preclinical imaging capabilities